TGFB1 and non-small cell lung carcinoma: TGFB1 showed a positive correlation with NSCLC risk through inverse variance weighted analysis (OR = 1.173, 95% CI: 1.025–1.343, p = 0.020), suggesting that elevated TGFB1 levels may increase the risk of developing NSCLC.